Ebony C. Liu is an ophthalmologist based in Adelaide, SA, Australia. She looks after people with eye problems that affect the retina and the macula, the part of the eye that helps with sharp, clear vision.
In many cases, her work involves supporting patients who have diabetes. This includes diabetic retinopathy and diabetic macular oedema (DME), which can slowly change how the eye works over time. She also sees people with type 1 and type 2 diabetes, and those with related health issues where eye checks matter as part of the bigger picture.
Ebony also treats age-related macular degeneration (ARMD). This is common as we get older, and it can make reading, driving, or recognising faces feel harder. Depending on the situation, she may focus on slowing vision changes and managing symptoms that come with macular disease.
Some patients need more than clinic care. Ebony provides surgical treatment including vitrectomy. That can be used when there are issues inside the eye, and at times when the eye needs closer repair work to help protect vision.
Other conditions she helps with include late-onset retinal degeneration and Wilson disease. These are eye conditions that can affect the retina in different ways, so the approach is usually guided by what is happening in the eye on scans and exam findings.
Over time, her approach is practical and patient-led. She explains what is going on, what treatment options are available, and what to watch for between visits. At times, that means bringing together eye care with general health planning, especially when diabetes is part of the story.
Her experience is grounded in day-to-day ophthalmology care, including follow-up for long-term retinal conditions and treatment planning for patients who need ongoing monitoring. Education details aren’t listed here, but she does keep learning with updates that help with modern retinal treatment and eye imaging.
Information about research and clinical trials isn’t provided here. What is clear is that she works with retinal conditions that can change slowly, so regular review matters, and earlier checks can make a difference for vision outcomes.
